CHAOJU EYE CARE HOLDINGS LIMITED. SUCCESSFULLY LISTED ON HKEX
Latest Update:
7 th July, 2021

On July 7, 2021, Chaoju Eye Care Holdings Limited (hereinafter referred to as "Chaoju Eye Care") (02219.HK) was successfully listed on the main board of the Stock Exchange of Hong Kong, with a maximum increase of over 53% on the first day of trading.

Haitong International Capital Limited and Huatai Financial Holdings (Hong Kong) Limited are the co-sponsors; Haitong International Securities Limited and Huatai Financial Holdings (Hong Kong) Limited are the joint global coordinators, joint bookrunners and joint lead managers.

As the financial pr consultant team of the company, Porda Havas participated in the whole process of the company's listing, including the maintenance of domestic and foreign media relations, the design and production of listing publicity materials, and the holding of listing celebrations, helping the company to be listed in Hong Kong.

It is reported that in the Hong Kong public offering stage, Chaoju Eye Care was 113.97 times subscribed, and the final number of shares sold to the public was 85.465 million, accounting for 50% of the total number of shares sold. A total of 153,300 valid applications were received, with a winning rate of 5.67%. 18 successful bids were received.

About Chaoju Eye Care Holdings Limited

Chaoju Eye Care Holdings Limited (stock code: 2219), founded in 1988 in Baotou, Inner Mongolia, is a leading and nationally renowned eye medical service group in North China. Since its establishment, Chaoju Eye Care has been adhering to the vision of "gathering for one hundred years, facing the light and gathering hope", providing patients with a safe and affordable ophthalmic medical environment, professional and effective equipment and technology, and intimate and humane service experience. Over the years, the company has established an extensive network of eye hospitals and optometry centers across five provinces or autonomous regions in North China.

Latest Update:
7 th July, 2021